부산대학교 도서관

Mustapha, Mubarak Taiwo; Onakpojeruo, Efe Precious; David, Leena R.; Uzun, Berna; Hussain, Abir Jaafar; Ozsahin, Dilber Uzun

2024 17th International Conference on Development in eSystem Engineering (DeSE) Development in eSystem Engineering (DeSE), 2024 17th International Conference on. :399-404 Nov, 2024

Chopra, Sejal; Shukla, Jaya; Purohit, Priyavrat; Adhikari, Umanath; Roesch, Frank; Moon, Euy Sung; Rathore, Yogesh; Rana, Nivedita; Bhadada, Sanjay Kumar; Mittal, Bhagwant Rai; Walia, Rama

European Journal of Nuclear Medicine and Molecular Imaging. 52(10):3618-3631

Guarnotta, Valentina; Stigliano, Antonio; Terzolo, Massimo; Arnaldi, Giorgio

Reviews in Endocrine and Metabolic Disorders. :1-13

Oncology and Therapy. 13(2):307-323

Chao Y; Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.; Zhu H; Department of Radiology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.; Yang W; School of Automation Science and Engineering, South China University of Technology, Guangzhou, 510640, China.; Yao H; Department of Urology, Guangdong Provincial People's Hospital, Guangzhou, China.; Ma N; Department of Urology, Sun Yat-sen University Cancer Center, Sun Yat-sen University, Guangzhou, 510060, China.; State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.; Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China.; Chen X; Department of Urology, Sun Yat-sen University Cancer Center, Sun Yat-sen University, Guangzhou, 510060, China.; State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.; Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China.; Zhao J; State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.; Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China.; Department of Radiology, Sun Yat-sen University Cancer Center, Sun Yat-sen University, Guangzhou, China.; Ma H; State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.; Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China.; Department of Radiology, Sun Yat-sen University Cancer Center, Sun Yat-sen University, Guangzhou, China.; Liu Z; Department of Urology, Sun Yat-sen University Cancer Center, Sun Yat-sen University, Guangzhou, 510060, China.; State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.; Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China.; Han H; Department of Urology, Sun Yat-sen University Cancer Center, Sun Yat-sen University, Guangzhou, 510060, China.; State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.; Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China.; Liu Z; Department of Urology, Sun Yat-sen University Cancer Center, Sun Yat-sen University, Guangzhou, 510060, China.; State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.; Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China.; Department of Urology, Sun Yat-sen University Cancer Center Gansu Hospital, Sun Yat-sen University, Lanzhou, China.; Yao K; Department of Urology, Sun Yat-sen University Cancer Center, Sun Yat-sen University, Guangzhou, 510060, China.; State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.; Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China.; Li Y; Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China.; Wu P; Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China.; Zhang J; Department of Urology, Sun Yat-sen University Cancer Center, Sun Yat-sen University, Guangzhou, 510060, China. zhangjt@sysucc.org.cn.; State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China. zhangjt@sysucc.org.cn.; Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China. zhangjt@sysucc.org.cn.; Li B; School of Automation Science and Engineering, South China University of Technology, Guangzhou, 510640, China. binlee@scut.edu.cn.; Guo S; Department of Urology, Sun Yat-sen University Cancer Center, Sun Yat-sen University, Guangzhou, 510060, China. guoshj@sysucc.org.cn.; State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China. guoshj@sysucc.org.cn.; Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, China. guoshj@sysucc.org.cn.

Publisher: BioMed Central Country of Publication: England NLM ID: 100968553 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2342 (Electronic) Linking ISSN: 14712342 NLM ISO Abbreviation: BMC Med Imaging Subsets: MEDLINE

Oguni K; Department of Endocrinology and Metabolism, Toranomon Hospital, Japan.; Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan.; Goshima Y; Department of Endocrinology and Metabolism, Toranomon Hospital, Japan.; Tatsushima K; Department of Endocrinology and Metabolism, Toranomon Hospital, Japan.; Hayashida M; Department of Urology, Toranomon Hospital, Japan.; Urakami S; Department of Urology, Toranomon Hospital, Japan.; Ito S; Department of Pathology, Toranomon Hospital, Japan.; Yamazaki Y; Department of Pathology, Tohoku University Graduate School of Medicine, Japan.; Sasano H; Department of Pathology, Tohoku University Graduate School of Medicine, Japan.; Takeuchi Y; Department of Endocrinology and Metabolism, Toranomon Hospital, Japan.; Okinaka Memorial Institute for Medical Research, Japan.; Takeshita A; Department of Endocrinology and Metabolism, Toranomon Hospital, Japan.; Okinaka Memorial Institute for Medical Research, Japan.

Publisher: Japanese Society of Internal Medicine Country of Publication: Japan NLM ID: 9204241 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7235 (Electronic) Linking ISSN: 09182918 NLM ISO Abbreviation: Intern Med Subsets: MEDLINE

Jafari Z; Department of Cell and Molecular Biology and Microbiology, Faculty of Biological Science and Technology, University of Isfahan, Isfahan, 81746-73441, Iran.; Javadirad SM; Department of Cell and Molecular Biology and Microbiology, Faculty of Biological Science and Technology, University of Isfahan, Isfahan, 81746-73441, Iran. javadirad@yahoo.com.; Yazdi Rouholamini SE; Department of Cell and Molecular Biology and Microbiology, Faculty of Biological Science and Technology, University of Isfahan, Isfahan, 81746-73441, Iran.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

Butz H; Department of Molecular Genetics and the National Tumour Biology Laboratory, National Institute of Oncology, Comprehensive Cancer Centre, 7-9 Rath Gyorgy utca, H-1122 Budapest, Hungary.; Department of Oncology Biobank, National Institute of Oncology, Comprehensive Cancer Centre, 7-9 Rath Gyorgy utca, H-1122 Budapest, Hungary.; HUN-REN-OOI-TTK-HCEMM Oncogenomics Research Group, 7-9 Rath Gyorgy utca, H-1122 Budapest, Hungary.; Department of Laboratory Medicine, Semmelweis University, 4 Nagyvarad ter, H-1089 Budapest, Hungary.; Pongor L; HUN-REN-OOI-TTK-HCEMM Oncogenomics Research Group, 7-9 Rath Gyorgy utca, H-1122 Budapest, Hungary.; Cancer Genomics and Epigenetics Core Group, Hungarian Centre of Excellence for Molecular Medicine, 9 Budapesti ut, H-6728 Szeged, Hungary.; Krokker L; Department of Laboratory Medicine, Semmelweis University, 4 Nagyvarad ter, H-1089 Budapest, Hungary.; Szabó B; Department of Laboratory Medicine, Semmelweis University, 4 Nagyvarad ter, H-1089 Budapest, Hungary.; Dezső K; Department of Pathology and Experimental Cancer Research, Semmelweis University, 26. Ulloi ut, H-1085 Budapest, Hungary.; Dankó T; Department of Pathology and Experimental Cancer Research, Semmelweis University, 26. Ulloi ut, H-1085 Budapest, Hungary.; Sebestyén A; Department of Pathology and Experimental Cancer Research, Semmelweis University, 26. Ulloi ut, H-1085 Budapest, Hungary.; Sztankovics D; Department of Pathology and Experimental Cancer Research, Semmelweis University, 26. Ulloi ut, H-1085 Budapest, Hungary.; Tóvári J; Department of Experimental Pharmacology and the National Tumour Biology Laboratory, National Institute of Oncology, Comprehensive Cancer Centre, 7-9 Rath Gyorgy utca, H-1122 Budapest, Hungary.; Surguta SE; Department of Experimental Pharmacology and the National Tumour Biology Laboratory, National Institute of Oncology, Comprehensive Cancer Centre, 7-9 Rath Gyorgy utca, H-1122 Budapest, Hungary.; Likó I; Department of Molecular Genetics and the National Tumour Biology Laboratory, National Institute of Oncology, Comprehensive Cancer Centre, 7-9 Rath Gyorgy utca, H-1122 Budapest, Hungary.; HUN-REN-OOI-TTK-HCEMM Oncogenomics Research Group, 7-9 Rath Gyorgy utca, H-1122 Budapest, Hungary.; Mészáros K; Department of Laboratory Medicine, Semmelweis University, 4 Nagyvarad ter, H-1089 Budapest, Hungary.; Deák A; Artificial Transporter Research Group, Institute of Materials and Environmental Chemistry, Research Centre for Natural Sciences, 2 Magyar Tudosok korutja, H-1117 Budapest, Hungary.; Fekete F; Department of Oncology Biobank, National Institute of Oncology, Comprehensive Cancer Centre, 7-9 Rath Gyorgy utca, H-1122 Budapest, Hungary.; Vida R; Department of Oncology Biobank, National Institute of Oncology, Comprehensive Cancer Centre, 7-9 Rath Gyorgy utca, H-1122 Budapest, Hungary.; Báthory-Fülöp L; Department of Surgical and Molecular Pathology and the National Tumour Biology Laboratory, National Institute of Oncology, Comprehensive Cancer Centre, 7-9 Rath Gyorgy utca, H-1122 Budapest, Hungary.; Tóth E; Department of Surgical and Molecular Pathology and the National Tumour Biology Laboratory, National Institute of Oncology, Comprehensive Cancer Centre, 7-9 Rath Gyorgy utca, H-1122 Budapest, Hungary.; Igaz P; Department of Endocrinology, Faculty of Medicine, Semmelweis University, 26. Ulloi ut, H-1085 Budapest, Hungary.; Department of Internal Medicine and Oncology, Faculty of Medicine, Semmelweis University, 2 Koranyi Sandor, utca, H-1083 Budapest, Hungary.; Patócs A; Department of Molecular Genetics and the National Tumour Biology Laboratory, National Institute of Oncology, Comprehensive Cancer Centre, 7-9 Rath Gyorgy utca, H-1122 Budapest, Hungary.; HUN-REN-OOI-TTK-HCEMM Oncogenomics Research Group, 7-9 Rath Gyorgy utca, H-1122 Budapest, Hungary.; Department of Laboratory Medicine, Semmelweis University, 4 Nagyvarad ter, H-1089 Budapest, Hungary.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

Muzzi JCD; Pelé Pequeno Príncipe Research Institute, Curitiba 80250-060, Brazil.; Bioinformatics and Systems Biology Laboratory, Federal University of Paraná (UFPR), Curitiba 81520-260, Brazil.; Ruggiero C; Institut de Pharmacologie Moleculaire et Cellulaire CNRS UMR 7275, Valbonne 06560, France.; Universite Côte d'Azur, Valbonne 06560, France.; Doghman-Bouguerra M; Institut de Pharmacologie Moleculaire et Cellulaire CNRS UMR 7275, Valbonne 06560, France.; Universite Côte d'Azur, Valbonne 06560, France.; Colodel ME; Pelé Pequeno Príncipe Research Institute, Curitiba 80250-060, Brazil.; Magno JM; Pelé Pequeno Príncipe Research Institute, Curitiba 80250-060, Brazil.; Bioinformatics and Systems Biology Laboratory, Federal University of Paraná (UFPR), Curitiba 81520-260, Brazil.; Resende JSS; Pelé Pequeno Príncipe Research Institute, Curitiba 80250-060, Brazil.; Bioinformatics and Systems Biology Laboratory, Federal University of Paraná (UFPR), Curitiba 81520-260, Brazil.; Durand N; Institut de Pharmacologie Moleculaire et Cellulaire CNRS UMR 7275, Valbonne 06560, France.; Universite Côte d'Azur, Valbonne 06560, France.; de Moura JF; Department of Basic Pathology, Federal University of Paraná (UFPR), Curitiba 81530-990, Brazil.; Alvarenga LM; Department of Basic Pathology, Federal University of Paraná (UFPR), Curitiba 81530-990, Brazil.; Cavalli LR; Pelé Pequeno Príncipe Research Institute, Curitiba 80250-060, Brazil.; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, United States.; Figueiredo BC; Pelé Pequeno Príncipe Research Institute, Curitiba 80250-060, Brazil.; Faculdades Pequeno Príncipe, Curitiba, PR 80230-020, Brazil.; Lalli E; Institut de Pharmacologie Moleculaire et Cellulaire CNRS UMR 7275, Valbonne 06560, France.; Universite Côte d'Azur, Valbonne 06560, France.; Inserm, Valbonne 06560, France.; Castro MAA; Bioinformatics and Systems Biology Laboratory, Federal University of Paraná (UFPR), Curitiba 81520-260, Brazil.

Publisher: Oxford University Press Country of Publication: England NLM ID: 9423848 Publication Model: Print Cited Medium: Internet ISSN: 1479-683X (Electronic) Linking ISSN: 08044643 NLM ISO Abbreviation: Eur J Endocrinol Subsets: MEDLINE

Yang Q; School of Basic Medical Sciences and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China.; Sun Q; College of Information Technology, ZheJiang Shuren University, Hangzhou, China.; Zhang Y; School of Basic Medical Sciences and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China.; Gong R; Department of Laboratory Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.; Wang M; Laboratory of Behavioral Neuroscience, Ningbo Kangning Hospital, Ningbo Institute of Microcirculation and Henbane, School of Medicine, Ningbo University, Ningbo, Zhejiang, China.; Li J; Xi'an Key Laboratory of Stem Cell and Regenerative Medicine, Institute of Medical Research, Northwestern Polytechnical University, Xi'an, Shaanxi, China.; Lai M; School of Basic Medical Sciences and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China. lmd@cpu.edu.cn.; Department of Pathology, Research Unit of Intelligence Classification of Tumor Pathology and Precision Therapy, Chinese Academy of Medical Science, Zhejiang University School of Medicine, Hangzhou, China. lmd@cpu.edu.cn.; Lai C; Department of Urology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. clai8827@zju.edu.cn.

Publisher: Springer Country of Publication: United States NLM ID: 101274889 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-3890 (Electronic) Linking ISSN: 15733882 NLM ISO Abbreviation: Metabolomics Subsets: MEDLINE

Zhu J; Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; Yan R; Eight-Year Medical Doctor Program, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Shen J; Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; Miao Z; Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; Shen J; Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; Hu K; Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.; Zhang F; Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

Publisher: Blackwell Pub. Asia Country of Publication: Australia NLM ID: 101241430 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1743-7563 (Electronic) Linking ISSN: 17437555 NLM ISO Abbreviation: Asia Pac J Clin Oncol Subsets: MEDLINE

Lopez J; GCS AURAGEN, Lyon, France.; Biochemistry and Molecular Biology Department, Hospices Civils de Lyon, Hôpital Lyon Sud, Pierre-Bénite, France.; Buisson A; GCS AURAGEN, Lyon, France.; Department of Biopathology, Centre Léon Bérard, Lyon, France.; Ounnas A; GCS AURAGEN, Lyon, France.; Tachon G; GCS AURAGEN, Lyon, France.; Department of Biopathology, Centre Léon Bérard, Lyon, France.; Viari A; GCS AURAGEN, Lyon, France.; De Fraipont F; GCS AURAGEN, Lyon, France.; Medical Unit of Molecular Genetics, Grenoble University Hospital, Grenoble, France.; Albuisson J; GCS AURAGEN, Lyon, France.; Department of Pathology and Tumor Biology, Georges-François Leclerc Center, Dijon, France.; Barritault M; GCS AURAGEN, Lyon, France.; Department of Pathology, Groupe Hospitalier Est, Hospices Civils de Lyon, Bron, France.; Bringuier PP; GCS AURAGEN, Lyon, France.; Department of Pathology, Groupe Hospitalier Est, Hospices Civils de Lyon, Bron, France.; Feugeas JP; GCS AURAGEN, Lyon, France.; Laboratoire de Biochimie Hôpital Jean Minjoz, Université de Franche-Comté, Besançon, France.; Mc Leer A; GCS AURAGEN, Lyon, France.; Department of Biopathology, Centre Léon Bérard, Lyon, France.; Bouras A; GCS AURAGEN, Lyon, France.; Laboratory of Constitutional Genetics for Frequent Cancer HCL-CLB, Centre Léon Bérard, Lyon, France.

Publisher: Munksgaard Country of Publication: Denmark NLM ID: 0253664 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1399-0004 (Electronic) Linking ISSN: 00099163 NLM ISO Abbreviation: Clin Genet Subsets: MEDLINE

Cemiplimab as Maintenance Treatment for Advanced Adrenocortical Cancer
Powles T, Park SH, Caserta C, Valderrama BP, Gurney H, Ullen A, Loriot Y, Sridhar SS, Sternberg CN, Bellmunt J, Aragon-Ching JB, Wang J, Huang B, Laliberte RJ, di Pietro A, Grivas P. Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Results From the JAVELIN Bladder 100 Trial After >/=2 Years of Follow-Up. J Clin Oncol. 2023 Jul 1;41(19):3486-3492. doi: 10.1200/JCO.22.01792. Epub 2023 Apr 18.
Powles T, Park SH, Voog E, Caserta C, Valderrama BP, Gurney H, Kalofonos H, Radulovic S, Demey W, Ullen A, Loriot Y, Sridhar SS, Tsuchiya N, Kopyltsov E, Sternberg CN, Bellmunt J, Aragon-Ching JB, Petrylak DP, Laliberte R, Wang J, Huang B, Davis C, Fowst C, Costa N, Blake-Haskins JA, di Pietro A, Grivas P. Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma. N Engl J Med. 2020 Sep 24;383(13):1218-1230. doi: 10.1056/NEJMoa2002788. Epub 2020 Sep 18.
Cosentini D, Grisanti S, Dalla Volta A, Lagana M, Fiorentini C, Perotti P, Sigala S, Berruti A. Immunotherapy failure in adrenocortical cancer: where next? Endocr Connect. 2018 Dec;7(12):E5-E8. doi: 10.1530/EC-18-0398.
Le Tourneau C, Hoimes C, Zarwan C, Wong DJ, Bauer S, Claus R, Wermke M, Hariharan S, von Heydebreck A, Kasturi V, Chand V, Gulley JL. Avelumab in patients with previously treated metastatic adrenocortical carcinoma: phase 1b results from the JAVELIN solid tumor trial. J Immunother Cancer. 2018 Oct 22;6(1):111. doi: 10.1186/s40425-018-0424-9.
Klein O, Senko C, Carlino MS, Markman B, Jackett L, Gao B, Lum C, Kee D, Behren A, Palmer J, Cebon J. Combination immunotherapy with ipilimumab and nivolumab in patients with advanced adrenocortical carcinoma: a subgroup analysis of CA209-538. Oncoimmunology. 2021 Apr 12;10(1):1908771. doi: 10.1080/2162402X.2021.1908771.
McGregor BA, Campbell MT, Xie W, Farah S, Bilen MA, Schmidt AL, Sonpavde GP, Kilbridge KL, Choudhury AD, Mortazavi A, Shah AY, Venkatesan AM, Bubley GJ, Siefker-Radtke AO, McKay RR, Choueiri TK. Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignancies. Cancer. 2021 Mar 15;127(6):840-849. doi: 10.1002/cncr.33328. Epub 2020 Nov 20.
Carneiro BA, Konda B, Costa RB, Costa RLB, Sagar V, Gursel DB, Kirschner LS, Chae YK, Abdulkadir SA, Rademaker A, Mahalingam D, Shah MH, Giles FJ. Nivolumab in Metastatic Adrenocortical Carcinoma: Results of a Phase 2 Trial. J Clin Endocrinol Metab. 2019 Dec 1;104(12):6193-6200. doi: 10.1210/jc.2019-00600.
Bedrose S, Miller KC, Altameemi L, Ali MS, Nassar S, Garg N, Daher M, Eaton KD, Yorio JT, Daniel DB, Campbell M, Bible KC, Ryder M, Chintakuntlawar AV, Habra MA. Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinoma. J Immunother Cancer. 2020 Jul;8(2):e001009. doi: 10.1136/jitc-2020-001009.
Habra MA, Stephen B, Campbell M, Hess K, Tapia C, Xu M, Rodon Ahnert J, Jimenez C, Lee JE, Perrier ND, Boraddus RR, Pant S, Subbiah V, Hong DS, Zarifa A, Fu S, Karp DD, Meric-Bernstam F, Naing A. Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma. J Immunother Cancer. 2019 Sep 18;7(1):253. doi: 10.1186/s40425-019-0722-x.
Naing A, Meric-Bernstam F, Stephen B, Karp DD, Hajjar J, Rodon Ahnert J, Piha-Paul SA, Colen RR, Jimenez C, Raghav KP, Ferrarotto R, Tu SM, Campbell M, Wang L, Sabir SH, Tapia C, Bernatchez C, Frumovitz M, Tannir N, Ravi V, Khan S, Painter JM, Abonofal A, Gong J, Alshawa A, McQuinn LM, Xu M, Ahmed S, Subbiah V, Hong DS, Pant S, Yap TA, Tsimberidou AM, Dumbrava EEI, Janku F, Fu S, Simon RM, Hess KR, Varadhachary GR, Habra MA. Phase 2 study of pembrolizumab in patients with advanced rare cancers. J Immunother Cancer. 2020 Mar;8(1):e000347. doi: 10.1136/jitc-2019-000347.
Grisanti S, Cosentini D, Lagana M, Volta AD, Palumbo C, Massimo Tiberio GA, Sigala S, Berruti A. The long and winding road to effective immunotherapy in patients with adrenocortical carcinoma. Future Oncol. 2020 Dec;16(36):3017-3020. doi: 10.2217/fon-2020-0686. Epub 2020 Aug 28. No abstract available.
Raj N, Zheng Y, Kelly V, Katz SS, Chou J, Do RKG, Capanu M, Zamarin D, Saltz LB, Ariyan CE, Untch BR, O'Reilly EM, Gopalan A, Berger MF, Olino K, Segal NH, Reidy-Lagunes DL. PD-1 Blockade in Advanced Adrenocortical Carcinoma. J Clin Oncol. 2020 Jan 1;38(1):71-80. doi: 10.1200/JCO.19.01586. Epub 2019 Oct 23.
Cremaschi V, Abate A, Cosentini D, Grisanti S, Rossini E, Lagana M, Tamburello M, Turla A, Sigala S, Berruti A. Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art? Expert Opin Pharmacother. 2022 Aug;23(12):1413-1424. doi: 10.1080/14656566.2022.2106128. Epub 2022 Aug 3.
Fassnacht M, Assie G, Baudin E, Eisenhofer G, de la Fouchardiere C, Haak HR, de Krijger R, Porpiglia F, Terzolo M, Berruti A; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020 Nov;31(11):1476-1490. doi: 10.1016/j.annonc.2020.08.2099. Epub 2020 Aug 27. No abstract available.
Berruti A, Baudin E, Gelderblom H, Haak HR, Porpiglia F, Fassnacht M, Pentheroudakis G; ESMO Guidelines Working Group. Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012 Oct;23 Suppl 7:vii131-8. doi: 10.1093/annonc/mds231. No abstract available.

A Phase I Dose-escalation Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma

A Phase II Study of Cabozantinib in Combination With Cemiplimab (Cabo-Cemiplimab) Versus Cabozantinib Alone in Adolescents and Adults With Advanced Adrenocortical Cancer

Phase II Study Evaluating the Efficacy of PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma

National Cancer Institute (NCI); Assistance Publique - Hôpitaux de Paris; University Hospital Wurzburg; University Hospital Munich; Skanes Universitetssjukhus

A Randomized Registry Trial of Adjuvant Mitotane vs. Mitotane With Cisplatin/Etoposide After Primary Surgical Resection of Localized Adrenocortical Carcinoma With High Risk of Recurrence (ADIUVO-2 Trial)

Hammer MM; Program Director, Thoracic Imaging Fellowship, Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts. Electronic address: mmhammer@bwh.harvard.edu.; Mayo-Smith WW; Harvard Medical School, Boston, Massachusetts; Vice Chair of Education, Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts.

Publisher: Elsevier Country of Publication: United States NLM ID: 101190326 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-349X (Electronic) Linking ISSN: 15461440 NLM ISO Abbreviation: J Am Coll Radiol Subsets: MEDLINE

Hu X; Department of Cardiology, The Fifth Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.; Arthur Vithran DT; Department of Orthopedics, Xiangya Hospital, Central South University, Changsha, Hunan, China.; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China.; Yang Z; Department of Cardiology, The Fifth Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.; Li H; Department of Cardiology, The Fifth Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.

Publisher: International Scientific Information, Inc Country of Publication: United States NLM ID: 101489566 Publication Model: Electronic Cited Medium: Internet ISSN: 1941-5923 (Electronic) Linking ISSN: 19415923 NLM ISO Abbreviation: Am J Case Rep Subsets: MEDLINE

Abe I; Department of Endocrinology and Diabetes Mellitus, Fukuoka University Chikushi Hospital, Chikushino, Fukuoka, Japan.; Yamazaki Y; Department of Pathology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.; Higashi A; Department of Endocrinology and Diabetes Mellitus, Fukuoka University Chikushi Hospital, Chikushino, Fukuoka, Japan.; Ochi K; Department of Endocrinology and Diabetes Mellitus, Fukuoka University Chikushi Hospital, Chikushino, Fukuoka, Japan.; Kubo K; Department of Endocrinology and Diabetes Mellitus, Fukuoka University Chikushi Hospital, Chikushino, Fukuoka, Japan.; Fujita Y; Department of Endocrinology and Diabetes Mellitus, Fukuoka University Chikushi Hospital, Chikushino, Fukuoka, Japan.; Takeshita K; Department of Endocrinology and Diabetes Mellitus, Fukuoka University Chikushi Hospital, Chikushino, Fukuoka, Japan.; Wada T; Department of Endocrinology and Diabetes Mellitus, Fukuoka University Chikushi Hospital, Chikushino, Fukuoka, Japan.; Mitsuoka R; Department of Endocrinology and Diabetes Mellitus, Fukuoka University Chikushi Hospital, Chikushino, Fukuoka, Japan.; Yamashita Y; Department of Endocrinology and Diabetes Mellitus, Fukuoka University Chikushi Hospital, Chikushino, Fukuoka, Japan.; Yoshida R; Department of Endocrinology and Diabetes Mellitus, Fukuoka University Chikushi Hospital, Chikushino, Fukuoka, Japan.; Kato T; Department of Endocrinology and Diabetes Mellitus, Fukuoka University Chikushi Hospital, Chikushino, Fukuoka, Japan.; Kudo T; Department of Endocrinology and Diabetes Mellitus, Fukuoka University Chikushi Hospital, Chikushino, Fukuoka, Japan.; Miyajima S; Department of Urology, Fukuoka University Chikushi Hospital, Chikushino, Fukuoka, Japan.; Ishii T; Department of Urology, Fukuoka University Chikushi Hospital, Chikushino, Fukuoka, Japan.; Nimura S; Department of Pathology, Fukuoka University Chikushi Hospital, Chikushino, Fukuoka, Japan.; Suzuki T; Department of Pathology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.; Sasano H; Department of Pathology, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.; Kobayashi K; Department of Endocrinology and Diabetes Mellitus, Fukuoka University Chikushi Hospital, Chikushino, Fukuoka, Japan.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE